Search Results - "Shiang, Alexander L"

Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer by Chauhan, Pradeep S, Alahi, Irfan, Sinha, Savar, Ledet, Elisa M, Mueller, Ryan, Linford, Jessica, Shiang, Alexander L, Webster, Jace, Greiner, Lilli, Yang, Breanna, Ni, Gabris, Dang, Ha X, Saha, Debanjan, Babbra, Ramandeep K, Feng, Wenjia, Harris, Peter K, Qaium, Faridi, Duose, Dzifa Y, Sanchez-Espitia, Alexander, Sherry, Alexander D, Jaeger, Ellen B, Miller, Patrick J, Caputo, Sydney A, Orme, Jacob J, Lucien, Fabrice, Park, Sean S, Tang, Chad, Pachynski, Russell K, Sartor, Oliver, Maher, Christopher A, Chaudhuri, Aadel A

“…Metastatic castration-resistant prostate cancer (mCRPC) resistant to androgen receptor signaling inhibitors (ARSIs) is often lethal. Liquid biopsy biomarkers…”
Get full text

Comparison of single-port and multi-port Retzius-sparing robot-assisted laparoscopic prostatectomy by Shiang, Alexander L., Palka, Joshua K., Balasubramanian, Shiva, Figenshau, R. Sherburne, Smith, Zachary L., Kim, Eric H.

“…Dissemination of robotic surgical technology for robot-assisted laparoscopic prostatectomy (RALP) has yielded advancements including the Retzius-sparing (RS)…”
Get full text

Abstract 983: Epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse prognosis in AR-altered lethal metastatic castration resistant prostate cancer by Chauhan, Pradeep Singh, Alahi, Irfan, Sinha, Savar, Mueller, Ryan, Shiang, Alexander L., Webster, Jace, Dang, Ha X., Saha, Debanjan, Greiner, Lilli, Yang, Breanna, Ledet, Elisa M., Babbra, Ramandeep K., Feng, Wenjia, Harris, Peter K., Qaium, Faridi, Jaeger, Ellen B., Miller, Patrick J., Caputo, Sydney A., Sartor, Oliver A., Pachynski, Russell K., Maher, Christopher A., Chaudhuri, Aadel A.

“…Abstract Background: Metastatic castration-resistant prostate cancer (mCRPC) resistant to androgen receptor (AR)-targeted agents is often lethal…”
Get full text

Abstract 2219: Urine cell-free DNA multi-omics to detect molecular residual disease and predict survival in bladder cancer patients by Chauhan, Pradeep Singh, Shiang, Alexander L., Alahi, Irfan, Sundby, R. Taylor, Feng, Wenjia, Gungoren, Bilge, Nawaf, Cayce, Chen, Kevin, Babbra, Ramandeep K., Harris, Peter K., Qaium, Faridi, Hatscher, Casey, Antiporda, Anna, Brunt, Lindsey, Mayer, Lindsey R., Shern, Jack F., Baumann, Brian C., Kim, Eric H., Reimers, Melissa A., Smith, Zachary L., Chaudhuri, Aadel A.

“…Abstract Background: Circulating cell-free tumor DNA (ctDNA) analysis for minimal residual disease (MRD) detection is transforming cancer care. However, the…”
Get full text

Abstract 6698: Combinatorial genomic and epigenomic cell-free DNA analysis of high-risk metastatic castration resistant prostate cancer reveals prognostic liquid biopsy signatures by Alahi, Irfan, Chauhan, Pradeep S., Shiang, Alexander L., Webster, Jace, Dang, Ha X., Greiner, Lilli, yang, Breanna, Ledet, Elisa M., Babbra, Ramandeep K., Feng, Wenjia, Harris, Peter K., Jaeger, Ellen B., Miller, Patrick J., Caputo, Sydney A., Santos, Giordano Cittolin, Sartor, Oliver, Pachynski, Russell K., Maher, Christopher A., Chaudhuri, Aadel A.

“…Abstract Background: Androgen receptor signaling inhibitors (ARSI) such abiraterone and enzalutamide have significantly improved clinical outcomes in…”
Get full text